Autism Spectrum Disorders (ASDs) are characterized by atypical sensory functioning in the visual, tactile, and auditory systems. Although less explored, olfactory changes have been reported in ASD patients. To explore these changes on a neural level, 18 adults with ASD and 18 healthy neurotypical controls were examined in a 2-phase study. Participants were first tested for odor threshold and odor identification. Then, (i) structural magnetic resonance (MR) images of the olfactory bulb were acquired, and (ii) a functional MR imaging olfaction study was conducted. ASD patients exhibited decreased function for odor thresholds and odor identification; this was accompanied by a relatively decreased activation in the piriform cortex. In conclusion, these findings suggest, that the known alterations in olfaction in ASD are rooted in the primary olfactory cortex.
Besides these two promising scientific investigations, the few clinical and scientific reports available that characterized olfactory function in this population suggested that individuals with ASD have atypical responses to olfactory stimuli (Bennetto et al. 2007; Schecklmann et al. 2013; Martin and Daniel 2014; Rozenkrantz et al. 2015; EndeveltShapira et al. 2018) , although the studies did not often agree. Whereas odor detection abilities were comparable in adults with ASD compared with controls in 3 studies (Suzuki et al. 2003; Tavassoli and BaronCohen 2012; Galle et al. 2013; Addo et al. 2017) , another study reported better odor detection in ASD patients (Ashwin et al. 2014) . Odor identification was comparable in one study (Addo et al. 2017) and impaired in three others (Suzuki et al. 2003; Galle et al. 2013; Wicker et al. 2016) . One important question remains to be examined is the neural mechanisms underlying such differences in smell perception in ASD patients. In other words, what olfactory system specificities do this population show? This study set out to examine this question, with 3 investigations. First (aim 1), we compared olfactory performance at both sensory and cognitive levels (i.e., odor threshold and odor identification tasks) between a sample of adults with ASD and a control group. Second, neural differences were analyzed at various processing levels, from olfactory bulb (OB) to more central olfactory areas, including the anterior and posterior piriform cortex, amygdala, and orbitofrontal cortex (OFC), classically shown to be activated during odor perception in brain imaging studies (Seubert et al. 2013) . Functional magnetic resonance imaging (fMRI) was used to explore functional olfactory system specificities in individuals with ASD. This was possible in areas such the piriform cortex, the amygdala, and the OFC. However, because the small size of the OB limits functional exploration in humans, we focalized on anatomical differences for this brain structure; we therefore compared the anatomical structure of the OB (aim 2), and functional odor-evoked activity in piriform cortex, amygdala, and OFC (aim 3) in ASD versus neurotypical (NT) participants. Literature in the field showed heterogeneity of results on structural and fMRI data in ASD (Anagnostou and Taylor 2011; Dichter 2012) and converge to the fact that there are both volume abnormalities and atypical functional activations (decreased in some areas, increased in others). Here, we examined whether such brain alterations may be applicable to the olfactory system by testing alternative hypotheses of decreased (or increased) volume in the OB and neural activations in piriform, amygdala, and orbitofrontal cortex. We further tested the hypothesis that the pattern (instead of the level) of activation may differ between groups in these brain areas.
Materials and methods

Participants
Eighteen adults with ASD (16 men, 2 women; mean age: 29.5 ± 2.51 years) and 18 healthy NT controls (15 men, 3 women; mean age: 29.5 ± 1.97 years) were examined. The current sample size was comparable to previous studies in the field using an average of 18 patients per experiment (n = 16 in Addo et al. [2017] ; n = 17 in Ashwin et al. [2014] ; n = 10 in Galle et al. [2013] , n = 15 in Wicker et al. [2016] ; n = 12 in Suzuki et al. [2003] ; and n = 38 in Tavassoli and Baron-Cohen [2012] ). Participants provided written informed consent to procedures approved by the ethical committee of the Medical Faculty of Technische Universität (TU) Dresden, Germany (application number EK 288092010). ASD patients were diagnosed in the outpatients clinic of the Department of Child and Adolescent Psychiatry and Psychotherapy of the TU Dresden, Germany. Only patients with Asperger syndrome and high-functioning autism were included. Diagnosis was based on standardized questionnaires, observations of behavior, interviews with patients and relatives, and Autism Diagnostic Interview-Revised and Autism Diagnostic Observation Schedule-Generic (obtained in 15 patients; mean ± standard deviation (SD): 11.06 ± 4.25; range: 6-19, which correspond to typical scores for ASD) questionnaires, administered by experienced observers. Exclusion criteria was composed of severe acute or chronic illness that might affect olfactory function; contraindications to MRI (e.g., pacemaker); and very sensitive nasal mucosa. In terms of depression scores (determined with the Beck Depression Inventory), there was a marginal but not significant difference between patients and controls (mean ± SD-ASD: 6.72 ± 5.79; NT: 3.83 ± 3.24; P = 0.073). Controls were selected through flyers put up on campus and through word of mouth. All controls were in excellent health as ascertained through a standardized medical history. Specifically, none of them reported current or past major psychological or psychiatric illness.
Olfactory psychophysics and questionnaire
The importance of olfaction in daily life was assessed by a structured questionnaire on the individual importance of olfaction . Olfactory thresholds and odor identification were assessed using pen-like odor dispensing devices ("Sniffin' Sticks"; Burghart, Wedel, Germany; Hummel et al. 2007 ). For odor presentation, the cap of the pen was removed by the experimenter and the tip was placed 2 cm in front of both nostrils (Figure 1a) .
Odor thresholds were determined using phenyl ethyl alcohol as odorant. Three pens were presented in random order, one containing the odorant at a certain dilution, and the others solvent only. The subject's task was to find out which of the pens were odorized. The stimuli were presented approximately every 20 s until subjects had correctly discerned the odorant in two successive trials, which triggered a reversal of the staircase. From a total of 7 reversals, the mean of the last 4 staircase reversal points was used as threshold estimate (Ehrenstein and Ehrenstein 1999) .
For odor identification, 16 odorants were sequentially presented; participants had to identify the odors from a list of 4 descriptors. Odor pens were presented at an interval of at least 30 s, to minimize olfactory desensitization (Köster and de Wijk 1991) .
Experimental design
MRI-based brain-imaging was performed on a 1.5 Tesla MR-scanner (Siemens Sonata, Erlangen, Germany). Two olfactory stimuli (Peach, P0606040, and Coffee, P0613905; Frey & Lau GmbH, HenstedtUlzburg, Germany) were presented to the left or right nostril using a computer-controlled olfactometer (rectangular-shaped stimuli, airflow 2 L/min (Sommer et al. 2012) ). These two odors were used because they are commonly rated as pleasant. We used two odors not with the intent to look for differences in the processing of the two odors but to make the experimental situation more interesting to the participants so that they would stay more alert during testing.
During the experiment, participants were asked to breathe through the mouth to limit respiratory airflow in the nasal cavity during chemosensory stimulation. From participant's arrival to departure, the experiment lasted approximately 60 min, comprising 4 sessions, randomized across all participants: peach/left nostril, peach/right nostril, coffee/left nostril, and coffee/right nostril. Each session had 6 ON/OFF-block subsessions. To minimize adaptation (Poellinger et al. 2001 ), we used 6 olfactory "ON" blocks lasting 20 s, comprising 8 trials of 1-s odor diffusion followed by 2-s clean air diffusion, alternating with 6 nonolfactory "OFF" blocks lasting 20 s without any odorant stimulation.
Brain imaging
OB volumes were measured for each participant on T2-weighted coronary images. The OB sequence included acquisition of 2-mm-thick T2-weighted fast spin-echo images, with 2 × 2 mm voxel size, without interslice gap in the coronal plane covering the anterior and middle segments of the base of the skull.
fMRI data were collected in 96 volumes/session (run duration: 240 s) with a 33 axial-slice gradient echo planar imaging (EPI) sequence (matrix: 64 × 64; time to repetition (TR): 2500 ms; time to echo (TE): 40 ms; flip angle: 90°; slice thickness: 3 mm; EPI slice gap: 0.75 mm; voxel size: 3 × 3 × 3 mm; field of view: 192 × 192 mm; interleaved acquisition). A high-resolution T2-weighted image of the OB was acquired (matrix: 256 × 256; TR: 4800 ms; TE: 125 ms; flip angle: 30°; slice thickness: 2 mm) (Figure 1b ). During the scanning sessions, participants were not cued for any stimulus presentation or aware of the identity of the stimuli during the sessions. They were not asked to perform any tasks during stimulus presentation.
Analysis
The psychophysical data (importance of olfaction questionnaire, threshold, and odor identification) were analyzed on univariate analyses of variance (ANOVA) with "group" as between-subjects factor. To obtain OB volumes, images were processed offline and left and right OB limits were drawn manually on each coronal slice using the AMIRA 3D visualization and modeling system (Visage Imaging). OB volumes were calculated by planimetric manual contouring (area in mm 2 ) and all areas were summed and multiplied by 2 (2-mm slice thickness) to obtain a volume in mm 3 . The sudden change in diameter at the beginning of the olfactory tract was used as the distal demarcation of the OB, as previously suggested (Yousem et al. 1997 (Yousem et al. , 1998 Buschhüter et al. 2008; Negoias et al. 2010; Croy et al. 2013; Hummel et al. 2013) . Results were statistically analyzed similarly as described for olfactory psychophysics.
fMRI data were analyzed with the SPM12 toolbox (Statistical Parametric Mapping; Welcome Department of Cognitive Neurology) implemented with Matlab 7.14 (version r2012; MathWorks Inc.). The preprocessing step was computed as a pipeline including motion correction, normalization using unified segmentation, and 8 × 8 × 8 mm 3 full width at half maximum Gaussian kernel smoothing to reduce between-subject physiologic variability. For each participant, odorinduced brain activity contrasted with the clean no-stimulus baseline was obtained by modeling voxel responses using a design matrix built with a canonical hemodynamic response function and experimental condition onsets. Motion parameters were also included as covariates in the model to remove potential confounding effects. A region of interest (ROI) approach was used in which neural activity in the anterior piriform cortex, posterior piriform cortex, amygdala, and OFC were extracted for each condition (odors vs. air; both the mean and the maximum signal (β) amplitude were extracted) and each participant (Figure 2 ). For left/right and anterior/posterior piriform cortex, ROIs were drawn using the MRIcro application, in 60 subjects who had participated in previous fMRI studies. Mean images and then binary masks were calculated using Imcalc in SPM; to keep a voxel in the binary mask, at least 30% of subjects had to have the voxel in their ROI. For the left/right amygdala and left/right OFC, ROIs were taken respectively from the "aal" template (Tzourio-Mazoyer et al. 2002) and the activation likelihood estimation maps created by Seubert et al. (2013) . fMRI data were analyzed for each area using univariate ANOVA with "group" (2: NT vs. ASD) as between-subjects factor and "hemisphere" (2: left vs. right, in piriform or amygdala or OFC) as within-subjects factor. In addition, and for piriform solely, we also considered the within-subjects factor "anteroposterior axis" (2: anterior vs. posterior). These statistical analyses were performed for both, the mean and the maximum signal (β) amplitude.
Finally, as well as the earlier univariate analysis, multivariate analysis was performed to discriminate odor-evoked neural patterns in each ROI between ASD and NT participants, using the Support Vector Machine (SVM) classification as implemented in scikit-learn (http://scikit-learn.org). The aim of this analysis was to predict (through a classification algorithm) whether the pattern of neural activation elicited by smells in a given ROI came from an individual from the ASD group or from the control group. SVM is a multivariate supervised classification technique introduced by Vapnik (2013) , and was successfully applied to neuroimaging (Mourão-Miranda et al. 2006) . The significance of classification performance was estimated using 1000 repetitions with group label permutations (see Golland et al. 2005) .
Results
Psychophysical data
Statistical analysis of psychophysical data indicated no significant effect of group for importance of olfaction in daily life (Table 1) . ASD patients and NT controls did not differ in importance questionnaire score or OB volume; however, patients had lower odor sensitivity and odor identification scores. F and P refer to the F-value and the P value of the ANOVA performed to test the group effect for each variable. a Significant differences between NT and ASD individuals (α level: 5%). Whereas ASD patients and NT controls did not differ in amygdala and OFC activation, patients had lower piriform cortex activity than controls. F and P refer to the F-value and the P value of the ANOVA performed to test the group effect for each variable. a Significant differences between NT and ASD individuals (α level: 5%).
Structural MRI data
trend was observed for the group effect on mean signal amplitude (mean β: F[1,34] = 3.185, P = 0.083, power = 0.618, η 2 p = 0.086, Table 2 ). These effects were accompanied by significant effects of hemisphere (max β: F[1,34] = 8.251, P = 0.007, power = 1.000, η Note that all these findings (except one) remained significant in piriform cortex when intersubject variability was taken into account by introducing the participants as random effect (for maximum signal amplitude: group effect: Multivariate analysis for piriform cortex did not reveal any significant difference in terms of spatial patterns evoked by odors in ASD versus NT individuals (anterior-left piriform cortex: accuracy = 39%, P = 0.860; anterior-right piriform cortex: 50%, P = 0.552; posterior-left piriform cortex: accuracy = 42%, P = 0.773; posterior-right piriform cortex: 58%, P = 0.287).
Regarding the amygdala, univariate analysis did not reveal any significant effect of group (max β: Table 2 ). There were also no significant intergroup differences groups in odor-evoked spatial patterns in the left (accuracy = 52%, P = 0.513) or right amygdala (56%, P = 0.413).
Finally, for the OFC, hemisphere effects were observed, with greater activity in the right than left OFC (max β Table 2 ). Multivariate analysis, however, revealed a trend toward significant difference between ASD and NT individuals in odor-evoked spatial pattern in the left (accuracy = 67%, P = 0.075) but not the right OFC (50%, P = 0.541; Figure 3 ).
Discussion
The aim of this study was threefold. Between ASD patients and NT individuals we explored 1) differences in odor detection and odor identification, 2) structural differences in the OB, and 3) odorinduced activity in the olfactory system, from piriform cortex to amygdala and OFC. Concerning the first aim, it was shown that ASD patients had higher thresholds (lower sensitivity) and lower odor identification scores than healthy participants. Regarding the second and third aims, no anatomical differences in the OB were observed between groups, but functional differences were detected in the piriform cortex, with lower neural activity when smelling odors in ASD patients than NT controls. One question that may be asked when considering these differences across groups is whether the control individuals were free from first degree relatives with a diagnosis of ASD. In our protocol, within the process of taking the medical history, all control participants were also asked for a diagnosis of ASD in one of their first-degree relatives. All controls reported that to their knowledge none of their relatives were diagnosed with ASD.
Perceptually, odor threshold appears more to concern peripheral sensitivity, whereas odor identification seems to relate more to cognitive processing (Lötsch et al. 2016; Whitcroft et al. 2017) . Clearly, the latter is not independent of the former: the mechanisms underlying odor identification involve different prior levels of processing, including odor detection (which depends on individual odor threshold), odor recognition (which consists in matching the olfactory percept with previously stored representations), and access to semantic and lexical representations in order to name the source of the odor. Investigations of odor sensitivity and odor identification in ASD patients reported impaired odor perception, although findings were inconsistent between studies. For instance, Suzuki et al. (2003) measured odor detection and odor identification abilities in adult patients with Asperger's syndrome and matched control subjects; patients exhibited intact odor detection but impaired odor identification. In contrast, odor detection was also reported to be better in ASD patients than in controls (Ashwin et al. 2014) . Galle et al. (2013) measured several aspects of olfactory perception (detection, discrimination, identification, and ratings for intensity, pleasantness, and familiarity) in ASD adults (including both classical autism and Asperger's syndrome) and controls; whereas olfactory thresholds, odor discrimination and intensity, pleasantness, and familiarity ratings did not differ between groups; odor identification ability was lower in classical autistic subjects than in both control and Asperger's syndrome subjects. This impairment of odor identification in ASD patients was replicated by one group (Wicker et al. 2016) but not by another (Addo et al. 2017). This study found impairment in both odor sensitivity and odor identification in ASD patients. These deficits in odor sensitivity and odor identification in ASD could not be due to age or gender differences (compare [Hummel et al. 2007] ), because the two groups did not differ for these two factors. Because ASD is characterized by a large heterogeneity across individuals in factors such as individual's intelligence and attentional abilities toward experimental tasks, one cannot discard the possibility that the observed perceptual differences were due to these cofactors. This experimental weakness is, however, diminished by the fact that we included in the protocol only patients with Asperger syndrome and high-functioning autism.
On the neural level, we were first interested in how the OB differs structurally between ASD patients and controls. Although previous studies showed anatomical specificities in this area in various pathological states characterized by olfactory loss, including schizophrenia (e.g., reduced OB volume; [Turetsky et al. 2000] ) and acute major depression , this analysis did not show such anatomical differences between the two groups. Here, one potential limitation of our study design concerns the relatively low number of participants, which may have impacted statistical power in this small area. Although the number of participants appears low, previous work has shown differences in OB volume in groups of similar size. For example, it has been shown that 19 patients with gradual improvement of olfactory function also exhibit a significant increase in OB volume (Gudziol et al. 2009 ). It should nevertheless be noted that this absence of structural difference (between groups) at the level of the OB does not in itself demonstrate that the observed olfactory perceptual variations (in threshold and in identification) start from the piriform cortex. It is possible that the OB is functionally impaired in people with ASD. To test this, future studies will need to look at cutting-edge methodology to explore the functions of the OB in humans.
Odor-induced activation in the piriform cortex was lower in ASD patients than NT controls. Previous studies suggested that the piriform cortex is more than an olfactory relay; it plays an active role from sensory to more cognitive aspects of odor perception including intensity and pleasantness coding. Studies suggest that an ongoing cognitive task can modulate piriform cortex activation (for a review, see Bensafi [2012] ). There is a dual odor representation within different portions of the piriform cortex: the anterior piriform cortex (recipient of structure-based code) should be viewed as a first relay from the OB and may process more physicochemical and sensorylike features of odorants; the posterior piriform cortex integrates odorant structure information into a qualitative representation and seems to integrate the identity of odor sources (Gottfried et al. 2006; Howard et al. 2009; Fournel et al. 2016) in association with other temporal and frontal areas (Grabenhorst and Rolls 2009; Olofsson et al. 2013) . It is therefore tempting to assume that the lower odor sensitivity in ASD than NT subjects may be reflected by lower activity in the anterior piriform cortex, and that poorer odor identification in ASD than NT subjects may be reflected by lower activity in the posterior piriform cortex. However, this analysis showed an overall decrease in piriform cortex activation, whether anterior or posterior, in response to odors in ASD compared with NT subjects. From this study, it can be concluded that it is the combined impairment of both odor sensitivity and odor identification that should be related to the decreased activity in the piriform cortex. Furthermore, a post hoc analysis correlating odor threshold and odor identification on the one hand (using mean-centered data), and neural activity in anterior piriform and posterior piriform on the other hand did not show any significant relationship between variables (odor threshold vs. anterior piriform: r = 0.126; odor threshold vs. posterior piriform: r = 0.264; odor identification vs. anterior piriform: r = 0.239; odor identification vs. posterior piriform: r = 0.154; n = 36 and P > 0.05 in all analyses).
In contrast to the above, no significant differences were observed in other olfactory-eloquent areas such as the amygdala or OFC. The amygdala is a heterogeneous structure of the medial temporal lobe, involved in emotional processing of sensory information. It plays a role in the processing of aversive (Morris et al. 1996; Zald and Pardo 1997) but also pleasant stimuli (Hamann et al. 2002) . Increased amygdala activity correlates with increased odor intensity (Anderson et al. 2003) , odor emotional salience (Winston et al. 2005) , and trigeminal sensitivity (Fournel et al. 2016) . Previous studies showed differential and/or lower activity in the amygdala during processing of affective touches (Kaiser et al. 2016) or faces (Kleinhans et al. 2016) in individuals with ASD. It should be noted that the absence of significant differences within the amygdala in our study may have been masked by the fact that the stimuli that we used have a relatively homogeneous emotional and social dimension (only pleasant food odors were used). Therefore, it would be of great interest in future olfaction studies to explore how the affective (e.g., pleasant/ unpleasant odors) and social (e.g., body odors) dimensions of smells modulate amygdala activity in ASD. OFC activity in response to smells reflected assignment of hedonic value (Anderson et al. 2003; Rolls et al. 2003) and was modulated by cognitive tasks (Zatorre et al. 2000) and semantic processing (Jones-Gotman and Zatorre 1993; de Araujo et al. 2005; Bensafi et al. 2014) . In this study, univariate statistical analysis did not reveal any significant difference in OFC activity between groups, but multivariate analysis showed a tendency (P = 0.07) toward a difference in left OFC activity following odor perception between ASD patients and NT controls. This trend could be further investigated in larger samples, and testing additional factors such as those cited earlier: namely the affective and social dimensions of smells. Another interesting aspect of this statistical trend is that it involves the left (and not the right) OFC. It would be unwise to draw conclusions on the basis of these nonsignificant hemispheric difference, but these data contribute to the ongoing debate on the lateralization of olfactory processes (Zatorre et al. 1992; Brand et al. 2001) and their relationship with emotional and linguistic treatments (Herz et al. 1999; Lorig 1999) .
In conclusion, this study offers new insights into odor perception in ASD patients, especially in Asperger's syndrome and high-functioning autism, highlighting, for the first time, that impaired olfaction in adult ASD patients is accompanied by a decrease in neural activity in the piriform cortex.
